Effect of mandibular advancement device treatment on HIF-1α, EPO and VEGF in the myocardium of obstructive sleep apnea–hypopnea syndrome rabbits

The aim of this study was to investigate the effects of mandibular advancement device (MAD) therapy for obstructive sleep apnea–hypopnea syndrome (OSAHS) on hypoxia-inducible factor-1α (HIF-1α), erythropoietin (EPO) and vascular endothelial growth factor (VEGF) in myocardial tissue. New Zealand rabb...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Dechao, Kang, Wenjing, Zhang, Shilong, Qiao, Xing, Liu, Jie, Liu, Chunyan, Lu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414037/
https://www.ncbi.nlm.nih.gov/pubmed/32764565
http://dx.doi.org/10.1038/s41598-020-70238-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414037/
https://www.ncbi.nlm.nih.gov/pubmed/32764565
http://dx.doi.org/10.1038/s41598-020-70238-0

Ejemplares similares